A meta-analysis comparing hyperfractionated vs. conventional fractionated radiotherapy in non-small cell lung cancer
Open Access
- 1 March 2015
- journal article
- research article
- Vol. 7 (3) , 478-485-485
Abstract
A meta-analysis comparing hyperfractionated vs. conventional fractionated radiotherapy in non-small cell lung cancerKeywords
This publication has 19 references indexed in Scilit:
- Radiotherapy for NSCLC: Review of conventional and new treatment techniquesJournal of Infection and Public Health, 2012
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and SurvivorshipMayo Clinic Proceedings, 2008
- Continuous hyperfractionated accelerated radiation therapy week-end less in combination with neoadjuvant chemotherapy for the treatment of stage III non-small-cell lung cancerLung Cancer, 2008
- Pre-treatment Haemoglobin Concentration in Accelerated and Conventional Radiotherapy for Non-small Cell Lung CarcinomaClinical Oncology, 2004
- Long term results of surgery versus continuous hyperfractionated accelerated radiotherapy (CHART) in patients aged >70 years with stage 1 non-small cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2003
- Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trialRadiotherapy and Oncology, 1999
- CHARTWEL-Bronchus (ARO 97-1)Strahlentherapie und Onkologie, 1997
- High-dose, hyperfractionated, accelerated radiotherapy using a concurrent boost for the treatment of nonsmall cell lung cancer: Unusual toxicity and promising early resultsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996
- The rationale for continuous, hyperfractionated, accelerated radiotherapy (chart)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1990
- Radiotherapy employing three fractions in each day over a continuous period of 12 daysBritish Journal of Radiology, 1986